These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35155438)

  • 41. Analysis of damage-associated molecular patterns in amyotrophic lateral sclerosis based on ScRNA-seq and bulk RNA-seq data.
    Shi Y; Zhu R
    Front Neurosci; 2023; 17():1259742. PubMed ID: 37942135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
    Zhang Y; Lu H; Zhang J; Wang S
    Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Nomogram Associated with Longer Survival in Amyotrophic Lateral Sclerosis Patients.
    Wei QQ; Chen Y; Chen X; Cao B; Ou R; Zhang L; Hou Y; Shang H
    Aging Dis; 2018 Dec; 9(6):965-975. PubMed ID: 30574410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma.
    Liu R; Jiang Z; Kong W; Zheng S; Dai T; Wang G
    Front Genet; 2021; 12():730732. PubMed ID: 34917126
    [No Abstract]   [Full Text] [Related]  

  • 48. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
    Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X
    Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
    Kang K; Xie F; Mao J; Bai Y; Wang X
    Front Oncol; 2020; 10():573141. PubMed ID: 33072607
    [No Abstract]   [Full Text] [Related]  

  • 51. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.
    Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
    J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.
    Xu D; Wang Y; Wu J; Zhang Y; Liu Z; Chen Y; Zheng J
    Front Cell Dev Biol; 2021; 9():686664. PubMed ID: 34631695
    [No Abstract]   [Full Text] [Related]  

  • 53. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 54. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 56. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
    Zheng W; Chen C; Yu J; Jin C; Han T
    BMC Cancer; 2021 Apr; 21(1):345. PubMed ID: 33794814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients.
    Guo C; Dong C; Zhang J; Wang R; Wang Z; Zhou J; Wang W; Ji B; Ma B; Ge Y; Wang Z
    Front Med (Lausanne); 2021; 8():716869. PubMed ID: 34350203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma.
    Xiao Z; Li J; Yu Q; Zhou T; Duan J; Yang Z; Liu C; Xu F
    Front Pharmacol; 2021; 12():778294. PubMed ID: 35002712
    [No Abstract]   [Full Text] [Related]  

  • 60. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
    Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
    Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.